World News: 09:00 GMT Friday 15th March 2019. [Royal Philips via Globe Newswire via SPi World News]
March 15, 2019
“At Philips we provide intelligent solutions that help clinicians to be more efficient and effective, enabling them to deliver a consistent standard of care, optimize care pathways, simplify workflows and drive better treatment outcomes,” said , Chief Business Leader Image Guided Therapy, Philips. “We continue to accelerate our pace of innovation. We recently introduced Azurion with FlexArm, the latest development on our leading platform for interventional procedures, as well as the new generation of IntelliSpace Cardiovascular, our multi-modality cardiovascular image and information management solution.”
At ACC.19 Philips will announce the presentation of data from the DEFINE-PCI study, which has assessed the level of residual ischemia found in patients after percutaneous coronary interventions (PCI).
For more information on Philips' integrated cardiology solutions, visit Philip’s booth (#2811) at ACC.19 or visit the . Follow the #ACC19 conversation on throughout the event.
Mark GrovesPhilips Group Press OfficeTel: +31 631 639 916 Email: Twitter:
Globe Newswire: 09:00 GMT Friday 15th March 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.